Klinikum Oldenburg

Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial (2017) Fokas E, Stroebel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer G, Hartmann A, et al. Conference contribution ARHGEF9 disease: Phenotype clarification and genotype-phenotype correlation (2017) Alber M, Kalscheuer VM, Marco E, Sherr E, Lesca G, Till M, Gradek G, et al. Journal article Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100 (2017) Boeder NF, Doerr O, Bauer T, Mattesini A, Elsaesser A, Liebetrau C, Achenbach S, et al. Journal article Temporal trends in transcatheter and surgical aortic valve replacement : An analysis of aortic valve replacements in Germany during 2012-2014 (2017) Gaede L, Kim WK, Blumenstein J, Liebetrau C, Doerr O, Nef H, Hamm C, et al. Journal article Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma (2017) Einsele H, Knop S, Vogel M, Mueller J, Kropff M, Metzner B, Langer C, et al. Journal article Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial (2017) Einsele H, Engelhardt M, Tapprich C, Mueller J, Liebisch P, Langer C, Kropff M, et al. Journal article Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (2016) Theis FJ, Corbacioglu A, Gaidzik VI, Paschka P, Weber D, Bullinger L, Heuser M, et al. Journal article Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial (2016) Eigentler TK, Gutzmer R, Hauschild A, Heinzerling L, Schadendorf D, Nashan D, Hoelzle E, et al. Journal article A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance (2016) Boeder NF, Koepp T, Dorr O, Bauer T, Mattesini A, Elsasser A, Mollmann H, et al. Journal article